“Biotech stocks offer investors exposure to exciting innovations within healthcare and life sciences,” says Andrew Krei, co-chief investment officer of Crescent Grove Advisors. “These companies are often on the cutting edge and lead the development of breakthrough therapies.”
The biotech industry is an exciting place to be, but also a risky one. “The upside can be substantial, but new technologies can fail to materialize, wiping out equity values,” Krei says.
Read the full article here.